
Immunyx Pharma
Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.
About
Immunyx is a drug development company focused on modulating neutrophil function in disease. They are developing a targeted neutrophil nanoparticle platform (TENNs) to address challenges in neutrophil therapy, aiming to provide effective and safe treatments for deregulated neutrophil damage in diseases like COPD, cancer, colitis, and arthritis. Their technology aims to modify neutrophil toxicity without causing neutropenia.
Listed competitors
Also in this space
AI-driven digital twin of embryo development for cell-based therapies.
Shares Life Sciences, Therapeutics
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Therapeutics
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Therapeutics
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Clinical Trials
AI-driven platform for protein-level disease mapping and drug discovery.
Shares Life Sciences, Drug Discovery
AI-powered blood test for early cancer detection and subtyping.
Shares Life Sciences, Biotech
Key facts
- Website
- immunyx.com
- Headquarters
- New York, United States
- Founded
- 2017
- Employees
- 6
- Business model
- B2B
Tech stack
Detected on immunyx.com, last scanned 1 Nov 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Google Workspace
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Immunyx Pharma trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Immunyx Pharma is 60 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does Immunyx Pharma have?
Immunyx Pharma has approximately 6 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Immunyx Pharma:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


